Curcumin blocks interleukin-1 signaling in chondrosarcoma cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Kalinski, Thomas ^a   Sel, Saadettin ^b   Hütten, Heiko ^c   Röpke, Martin ^a   Roessner, Albert ^a   Nass, Norbert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; FAS LIGAND; I KAPPA B ALPHA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 3; VASCULOTROPIN A; INTERLEUKIN 1 RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CCL2 GENE; CHONDROSARCOMA CELL LINE; CONTROLLED STUDY; CSF2 GENE; DRUG EFFECT; FASLG GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE REPRESSION; HUMAN; HUMAN CELL; ICAM1 GENE; IKBKG GENE; IL 6 GENE; IN VITRO STUDY; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TLR3 GENE; TUMOR VASCULARIZATION; ANGIOGENESIS; ANTAGONISTS AND INHIBITORS; CHONDROSARCOMA; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL LINE, TUMOR; CHONDROSARCOMA; CURCUMIN; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84902440173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099296     Document Type: Article

References (39)

1. Apte RN, Voronov E (2008) Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol Rev. 222: 222-241. (Pubitemid 351430377)
2. Apte RN, Krelin Y, Song X, Dotan S, Recih E, et al. (2006) Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur J Cancer. 42: 751-759.
3. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, et al. (2003) IL1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A. 100: 2645-2650. (Pubitemid 36297552)
4. Martin MU, Wesche H (2002) Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta.1592: 265-280. (Pubitemid 35284883)
5. Liu G, Tsuruta Y, Gao Z, Park YJ, Abraham E (2007) Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. J Immunol. 179: 4125-4134.
6. Kawai T, Akira S (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 13: 460-469.
7. Bharti AC, Aggarwal BB (2002) Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol. 64: 883-888. (Pubitemid 35238030)
8. Kalinski T, Krueger S, Sel S, Werner K, Ropke M, et al. (2006) Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta. Cancer. 106: 2028-2038. (Pubitemid 43673220)
9. Kalinski T, Sel S, Kouznetsova I, Röpke M, Roessner A (2009) Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors. Pathol Res Pract. 205: 339-345.
10. Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 11: 495-510.
11. Jurrmann N, Brigelius-Flohé R, Böl GF (2005) Curcumin blocks interleukin-1 (IL-1) signaling by inhibiting the recruitment of the IL-1 receptor-associated kinase IRAK in murine thymoma EL-4 cells. J Nutr. 135: 1859-1864. (Pubitemid 41099742)
12. Kalinski T, Krueger S, Pelz AF, Wieacker P, Hartig R, et al. (2005) Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. Virchows Arch. 446: 287-299. (Pubitemid 40558385)
13. Lewis AM, Varghese S, Xu H, Alexander HR (2006) Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 4: 48.
14. Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, et al. (2007) Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 67: 1062-1071.
15. Lavi G, Voronov E, Dinarello CA, Apte RN, Cohen S (2007) Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases. J Control Release. 123: 123-130. (Pubitemid 47562137)
16. Song X, Voronov E, Dvorkin T, Fima E, Cagnano E, et al. (2003) Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J Immunol. 171: 6448-6456. (Pubitemid 37532073)
17. Dinarello CA (2010) Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev. 29: 317-329.
18. Kalinski T, Krueger S, Sel S, Werner K, Röpke M, et al. (2007) ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma. Hum Pathol. 38: 86-94. (Pubitemid 44880204)
19. Vincenti MP, Brinckerhoff CE (2001) Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res. 3: 381-388. (Pubitemid 33077119)
20. Gebauer M, Saas J, Sohler F, Haag J, Söder S, et al. (2005) Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta. Osteoarthritis Cartilage. 13: 697-708. (Pubitemid 41025123)
21. Fan Z, Söder S, Oehler S, Fundel K, Aigner T (2007) Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. Am J Pathol. 171: 938-946. (Pubitemid 47440992)
22. Bresnihan B, Cobby M (2003) Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology. 42 Suppl 2: ii22-28. (Pubitemid 37220897)
23. Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, et al. (2007) Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase- 2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol. 73: 1434-1445. (Pubitemid 46452591)
24. Henrotin Y, Clutterbuck AL, Allaway D, Lodwig EM, Harris P, et al. (2010) Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage. 18: 141-149.
25. Lay E, Samiric T, Handley CJ, Ilic MZ (2012) Short- and long-term exposure of articular cartilage to curcumin or quercetin inhibits aggrecan loss. J Nutr Biochem. 23: 106-112.
26. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell. 6: 203-208.
27. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med. 9: 669-676. (Pubitemid 36749215)
28. Csaki C, Mobasheri A, Shakibaei M (2009) Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther. 11: R165.
29. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269: 199-225.
30. Peschel D, Koerting R, Nass N (2007) Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem 18: 113-119. (Pubitemid 46048987)
31. Roomi MW, Kalinovsky T, Rath M, Niedzwiecki A (2014) In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol. 44: 27-34.
32. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, et al. (2007) NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13: 62-69. (Pubitemid 46067387)
33. Schweizerhof M, Stösser S, Kurejova M, Njoo C, Gangadharan V, et al. (2009) Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med 15: 802-807.
34. Grabstein KH, Urdal DL, Tushinski RJ, Mochizuki DY, Price VL, et al. (1986) Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232: 506-508. (Pubitemid 16052365)
35. Li T-M, Wu C-M, Huang H-C, Chou P-C, Fong Y-C, et al. (2012) Interleukin-11 increases cell motility and up-regulates intercellular adhesion molecule-1 expression in human chondrosarcoma cells. J Cell Biochem 113: 3353-3362.
36. Tang C-H, Tsai C-C (2012) CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway. Biochem Pharmacol 83: 335-344.
37. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm. 4: 807-818.
38. Pan MH, Huang TM, Lin JK (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. 27: 486-494.
39. Mosley CA, Liotta DC, Snyder JP (2007) Highly active anticancer curcumin analogues. Adv Exp Med Biol. 595: 77-103.